相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Myc-associated zinc finger protein (MAZ) works together with CTCF to control cohesin positioning and genome organization
Tiaojiang Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
miRNA-mediated loss of m6A increases nascent translation in glioblastoma
John P. Zepecki et al.
PLOS GENETICS (2021)
Evaluating single-cell cluster stability using the Jaccard similarity index
Ming Tang et al.
BIOINFORMATICS (2021)
Generalizing RNA velocity to transient cell states through dynamical modeling
Volker Bergen et al.
NATURE BIOTECHNOLOGY (2020)
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Charles P. Couturier et al.
NATURE COMMUNICATIONS (2020)
ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation
Mette Bentsen et al.
NATURE COMMUNICATIONS (2020)
Glioblastoma Stem cells: Driving Resilience through Chaos
Briana C. Prager et al.
TRENDS IN CANCER (2020)
The landscape of the mesenchymal signature in brain tumours
Jinan Behnan et al.
BRAIN (2019)
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
Anne Dirkse et al.
NATURE COMMUNICATIONS (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Astrogliosis Releases Pro-Oncogenic Chitinase 3-Like 1 Causing MAPK Signaling in Glioblastoma
Julian Wurm et al.
CANCERS (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor
J. P. Zepecki et al.
ONCOGENE (2019)
Identification of transcription factor binding sites using ATAC-seq
Zhijian Li et al.
GENOME BIOLOGY (2019)
Cellular Pliancy and the Multistep Process of Tumorigenesis
Alain Puisieux et al.
CANCER CELL (2018)
Enhancer RNA profiling predicts transcription factor activity
Joseph G. Azofeifa et al.
GENOME RESEARCH (2018)
Generalized Markov State Modeling Method for Nonequilibrium Biomolecular Dynamics: Exemplified on Amyloid β Conformational Dynamics Driven by an Oscillating Electric Field
Bernhard Reuter et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Detecting Differential Transcription Factor Activity from ATAC-Seq Data
Ignacio J. Tripodi et al.
MOLECULES (2018)
RNA velocity of single cells
Gioele La Manno et al.
NATURE (2018)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer
Frank vom Dorp et al.
JOURNAL OF UROLOGY (2016)
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop
Nis David Giladi et al.
ONCOTARGET (2015)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
Dong Whan Lee et al.
PLOS ONE (2013)
Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II
Humaira Gowher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
YKL-40 and MMP-9 as Serum Markers for Patients with Primary Central Nervous System Lymphoma
Andreas F. Hottinger et al.
ANNALS OF NEUROLOGY (2011)
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2011)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Identification of proteins secreted by human osteoblastic cells in culture
Julia S. Johansen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Overexpression of YKL-40 is an independent prognostic marker in gastric cancer
Jiong Bi et al.
HUMAN PATHOLOGY (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family
Jane D. Funkhouser et al.
BMC EVOLUTIONARY BIOLOGY (2007)
Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma
H Schmidt et al.
CANCER (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia
OJ Bergmann et al.
CLINICAL CANCER RESEARCH (2005)
YKL-40 expression is associated with poorer response to radiation end shorter overall survival in glioblastoma
CE Pelloski et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High serum YKL-40 level in patients with small cell lung cancer is related to early death
JS Johansen et al.
LUNG CANCER (2004)
分享论文
